IMMG Company Profile and Key Details

Q: Who are the executives of IMMG?

Mr. Zhi Cong MouChief Executive Officer, Pres, Treasurer, Sec. and DirectorMr. Elton F. Norman CPA, CPA, Esq., J.D.Chief Financial Officer and DirectorMr. Mahesh Narayanan M.S.Chief Operating Officer & Director

PNK : IMMG

Immage Biotherapeutics

$0.00

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Price Chart

Stock Price Today

Immage Biotherapeutics Corp. (IMMG) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.

Stock Snapshot

0.0001

Prev. Close

15.17K

Market Cap

0.000001

Day Low

-0.01

P/E Ratio

-0.01

EPS (TTM)

N/A

Cash Flow per Share

Open

151.74M

Number of Shares

0.0001

Day High

30.14%

Free Float in %

N/A

Book Value

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 18, 2025	0.00	0.00	0.00	0.00	0
Sep 15, 2025	0.00	0.00	0.00	0.00	0
Sep 11, 2025	0.00	0.00	0.00	0.00	0
Sep 08, 2025	0.00	0.00	0.00	0.00	0
Sep 04, 2025	0.00	0.00	0.00	0.00	0
Sep 02, 2025	0.00	0.00	0.00	0.00	0
Aug 26, 2025	0.00	0.00	0.00	0.00	0
Aug 22, 2025	0.00	0.00	0.00	0.00	1K
Aug 15, 2025	0.00	0.00	0.00	0.00	0
Aug 12, 2025	0.00	0.00	0.00	0.00	0
Aug 11, 2025	0.00	0.00	0.00	0.00	0
Aug 08, 2025	0.00	0.00	0.00	0.00	0
Aug 06, 2025	0.00	0.00	0.00	0.00	0
Aug 05, 2025	0.00	0.00	0.00	0.00	0
Aug 04, 2025	0.00	0.00	0.00	0.00	0
Jul 31, 2025	0.00	0.00	0.00	0.00	0
Jul 30, 2025	0.00	0.00	0.00	0.00	0
Jul 29, 2025	0.00	0.00	0.00	0.00	0
Jul 28, 2025	0.00	0.00	0.00	0.00	1K
Jul 25, 2025	0.00	0.00	0.00	0.00	1K

Contact Details

Bethesda, MD 20817

United States

https://www.immagebio.com 130 156 05411

About Company

Presently, Immage Biotherapeutics Corp. lacks substantial business operations. Historically, its endeavors centered on the creation of cutting-edge immunotherapy biologics designed to combat diverse cancer types across the United States. Established in 2012, the entity was initially known as Epicure Charcoal, Inc., rebranding to Immage Biotherapeutics Corp. in June 2015. Its corporate headquarters are situated in Bethesda, Maryland, and it operates as a subsidiary of Coventry International Limited.

Stock Peers

HALFF

2.25+1.81%

HAL Trust$126.75 SBHGF

-0.2-0.77%

SBI Holdings, Inc.$25.80 KNKBF

Kinnevik AB$11.71 SWSS

Springwater Special Situations Corp.$10.70 FFXXF

0.04+1.48%

Helios Fairfax Partners Corporation$2.74 AIMFF

-0.11-5.29%

Aimia Inc.$1.97 SWSSU

Springwater Special Situations Corp.$1.07 AVNI

Arvana Inc.$0.63 FGCO

Financial Gravity Companies, Inc.$0.40 TCRI

-0.018-12.15%

TechCom, Inc.$0.13

Company Overview

The stock is currently trading near its 52-week high $0.00 and $0.00. With a market capitalization of about $15.17 thousand, Immage Biotherapeutics Corp. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.01). Key stats such as the average daily volume over the past year has been around 211.00 shares, trading with heavier-than-usual volume. Headquartered in Bethesda, MD, Immage Biotherapeutics Corp. operates in the Financial Services sector and the Financial - Conglomerates industry. Led by CEO Zhi Cong Mou, the company employs approximately 3 people and listed since December 02, 2022. Presently, Immage Biotherapeutics Corp. lacks substantial business operations.

Valuation Metrics

Immage Biotherapeutics Corp. trades at a P/E ratio of -0.07, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 0.08 suggesting the stock is closer to book value. The P/FCF stands at -0.07, also above market averages.

Dividend & Fair Value

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Financial & Profitability Overview

Over the trailing twelve months, Immage Biotherapeutics has not generated any revenue.
On valuation metrics, Immage Biotherapeutics trades at a P/E of -0.07, P/S of 0.00 and P/B of 0.08. The current ratio is 3.67 and quick ratio is 3.67. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -130.50 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 0.28, supported by a cash flow-to-debt ratio of -4.09.

Price Forecast & Outlook

Our AI price prediction model suggests that Immage Biotherapeutics Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Key Takeaways

Valuation shows Immage Biotherapeutics Corp. trading at a premium to the broader market with a P/E of -0.07.

Frequently Asked Questions

What is the current Immage Biotherapeutics Corp. (IMMG) stock price?

Immage Biotherapeutics Corp. (OTC: IMMG) stock price is $0.00 in the last trading session. During the trading session, IMMG stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in IMMG stock occurred in the recent session was 0% while the dollar amount for the price change in IMMG stock was $0.00.

IMMG's industry and sector of operation?

The OTC listed IMMG is part of Financial - Conglomerates industry that operates in the broader Financial Services sector. Immage Biotherapeutics Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IMMG?

Mr. Zhi Cong Mou
Chief Executive Officer, Pres, Treasurer, Sec. and Director
Mr. Elton F. Norman CPA, CPA, Esq., J.D.
Chief Financial Officer and Director
Mr. Mahesh Narayanan M.S.
Chief Operating Officer & Director

How IMMG did perform over past 52-week?

IMMG's closing price is 0% higher than its 52-week low of $0.00 where as its distance from 52-week high of $0.00 is 0%.

How many employees does IMMG have?

Number of IMMG employees currently stands at 3.

Link for IMMG official website?

Official Website of IMMG is: https://www.immagebio.com

How do I contact IMMG?

IMMG could be contacted at phone 130 156 05411 and can also be accessed through its website. IMMG operates from 10411 Motor City Drive, Bethesda, MD 20817, United States.

How many shares of IMMG are traded daily?

IMMG stock volume for the day was 1K shares. The average number of IMMG shares traded daily for last 3 months was 211.

What is the market cap of IMMG currently?

The market value of IMMG currently stands at $15.17K with its latest stock price at $0.00 and 151.74M of its shares outstanding.

Employees	3
Beta	0.01
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	August
Sector	Financial Services
Industry	Financial - Conglomerates

IMMG Company Profile and Key Details

Immage Biotherapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Valuation Metrics

Dividend & Fair Value

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Dividend & Fair Value

Financial & Profitability Overview

Key Takeaways

Price Forecast & Outlook

Valuation Metrics